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Sperm−oocyte membrane fusion is one of the most important
events for fertilization. So far, IZUMO1 and Fertilization Influenc-
ing Membrane Protein (FIMP) on the sperm membrane and CD9
and JUNO (IZUMO1R/FOLR4) on the oocyte membrane have been
identified as fusion-required proteins. However, the molecular
mechanisms for sperm−oocyte fusion are still unclear. Here, we
show that testis-enriched genes, sperm−oocyte fusion required 1
(Sof1/Llcfc1/1700034O15Rik), transmembrane protein 95 (Tmem95),
and sperm acrosome associated 6 (Spaca6), encode sperm proteins
required for sperm−oocyte fusion in mice. These knockout (KO)
spermatozoa carry IZUMO1 but cannot fuse with the oocyte plasma
membrane, leading to male sterility. Transgenic mice which expressed
mouse Sof1, Tmem95, and Spaca6 rescued the sterility of Sof1,
Tmem95, and Spaca6KOmales, respectively. SOF1 and SPACA6 remain
in acrosome-reacted spermatozoa, and SPACA6 translocates to the
equatorial segment of these spermatozoa. The coexpression of SOF1,
TMEM95, and SPACA6 in IZUMO1-expressing cultured cells did not
enhance their ability to adhere to the oocyte membrane or allow them
to fuse with oocytes. SOF1, TMEM95, and SPACA6 may function co-
operatively with IZUMO1 and/or unknown fusogens in sperm−oocyte
fusion.
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There are many steps to complete fertilization, such as spermmigration through the female reproductive tract, the physi-
ological and morphological changes of spermatozoa (capacita-
tion, hyperactivation, and acrosome reaction), sperm−oocyte
interaction/fusion, and egg activation (1). During the last few
decades, gene knockout (KO) studies have revealed many critical
proteins for these steps (2–4). However, for the sperm−oocyte
fusion step, only four factors have been identified: CD9 and
JUNO expressed in oocytes and IZUMO1 and FIMP expressed
in spermatozoa.
In 2000, CD9, an integral membrane protein, was un-
intentionally found to be critical. Cd9 is ubiquitously expressed in
multiple tissues, and Cd9 KO male and female mice are healthy,
but the female mice show severe subfertility due to a sperm−
oocyte fusion defect (5–7). The later studies showed that CD9
acts as a scaffolding protein and is required for the normal mi-
crovillar shape and distribution (8). In 2005, we reported that
IZUMO1 is an essential factor for sperm−oocyte fusion (9).
IZUMO1 belongs to the Ig superfamily and is specifically
expressed in the testes. IZUMO1 is localized on the inner and
outer acrosome membranes in acrosome-intact spermatozoa,
and then translocated to the sperm plasma membrane after the
acrosome reaction (10, 11). Izumo1 KO spermatozoa can pen-
etrate the zona pellucida (ZP), but spermatozoa accumulate in
the perivitelline space due to a fusion defect (9). Since there is
no interaction found between IZUMO1 and CD9, the identifi-
cation of the IZUMO1 receptor had been challenging. In 2014,
by using oligomerized IZUMO1 ectodomains, Bianchi et al. (12)
succeeded in identifying a glycosylphosphatidylinositol-anchored
protein, JUNO (also known as IZUMO1 receptor [IZUMO1R]
and folate receptor 4 [FOLR4]) as an IZUMO1 receptor on the
oocyte plasma membrane. IZUMO1 and JUNO form a 1:1
complex (12), and critical residues to form this interaction were
identified by X-ray crystal structure analysis (13–15). However,
in vitro studies implied that IZUMO1 may be responsible for
sperm−oocyte membrane adhesion instead of fusion (16, 17).
Therefore, key mechanisms underlying the fusion step are yet to
be unveiled.
The emergence of the CRISPR-Cas9 system opened a new era
in mammalian genome editing (18–21). The CRISPR-KO ap-
proach efficiently screens male fertility genes in vivo. In fact, we
revealed that more than 90 genes are dispensable (22–26), while
10 genes and two clusters are required (21, 27–30) for male
fertility. Recently, we reported that a testis-specific gene,
4930451I11Rik (renamed as Fertilization Influencing Membrane
Protein [Fimp]), is another sperm factor critical for sperm−oocyte
fusion (31). While the amount and localization of IZUMO1 in
Fimp KO spermatozoa are normal, Fimp KO males are severely
subfertile due to a sperm−oocyte fusion defect. There are two
isoforms of FIMP (secreted and transmembrane forms), and we
showed that the transmembrane isoform is required for sperm−
oocyte fusion using transgenic (Tg) rescued Fimp KO males.
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Whereas IZUMO1-expressing HEK293T cells bound to oolemma,
FIMP did not directly mediate HEK293T cells−oolemma
binding/fusion or modulate IZUMO1-mediated binding/
fusion. Thus, the function of FIMP remains to be studied in
more detail.
In the present study, we focused on three testis-enriched genes
(sperm−oocyte fusion required 1 [Sof1], transmembrane protein
95 [Tmem95], and sperm acrosome membrane-associated pro-
tein 6 [Spaca6]), which are predicted as membrane proteins by
in silico analyses. The genes are also conserved in human. Sof1 is
originally registered as 1700034O15Rik in Mouse Genome In-
formatics and recently changed to Llcfc1 because it conserves an
“LLLL and CFNLAS” motif, but its physiological function re-
mains to be studied. Thus, we renamed it Sof1 to represent its
physiological function. Bull TMEM95 is localized to the acro-
some region, equatorial segment, and connecting piece of sper-
matozoa (32). Spermatozoa from a bull bearing biallelic
nonsense mutation in TMEM95 are defective in fusion to oocytes
(33). These results suggest that TMEM95 is required for the
sperm−oocyte interaction, but there remains a chance that un-
identified mutations are responsible for infertility. SPACA6 be-
longs to the Ig superfamily. Lorenzetti et al. (34) reported that
Spaca6messenger RNA (mRNA) was disrupted in BART97b Tg
male mice, which exhibited infertility and a sperm−oocyte fusion
defect. It suggests that SPACA6 is critical for sperm−oocyte
fusion, but the Tg insertion may affect the expression levels of
neighboring genes, rendering the essentiality of SPACA6
inconclusive.
In the present study, we generated Sof1, Tmem95, and Spaca6
KO mice using CRISPR-Cas9 and revealed that Sof1, Tmem95,
and Spaca6 KO males are sterile due to impaired sperm−oocyte
fusion. We could not observe any overt defects in the amount
and localization of IZUMO1 in the spermatozoa of each mutant
mouse. Our results suggest that sperm−oocyte fusion is a com-
plicated process that is mediated by multiple factors. Elucidation
of these proteins and their mechanisms of action will propel
progress toward our understanding of sperm−oocyte fusion and
idiopathic male infertility.
Results
In Silico Expression Analyses of Fusion-Related Sperm Genes. Using
published single-cell RNA-sequencing (scRNA-seq) data gen-
erated from mouse and human spermatogenic cells at different
stages (35), we found that the sperm-expressed proteins known
to be involved in sperm−oocyte membrane fusion (e.g.,
IZUMO1 and FIMP) exhibit an elevated mRNA expression in
round spermatids (SI Appendix, Fig. S1), the cell type in which
the proacrosomal vacuole forms. Specifically, during human and
mouse spermatogenesis, these mRNAs are initially detected in
early round spermatids, dramatically increase at the mid-
spermatid stage, and return to a low level in late round sper-
matids. Among the genes showing similar expression pattern
in silico, and given the possibility that the molecular mechanisms
underpinning gamete fusion are evolutionarily conserved, we
preferentially focused on sequences that encoded open reading
frames (ORFs) in a broad spectrum of species, including but not
limited to human and mice. Herein, we concentrated on the
functional analyses of Sof1, Tmem95, and Spaca6.
Sof1 Gene Deletion Male Mice Are Sterile. We performed expres-
sion analysis by RT-PCR with multiple tissues, and Sof1 mRNA
is abundantly expressed in the testis (Fig. 1A and SI Appendix,
Table S1). Sof1 mRNA was detected in testis after postnatal day
28 (Fig. 1B), indicating that Sof1 mRNA is expressed in sper-
matids. SOF1 is conserved in almost all mammals based on the
Ensemble database (accession #ENSMUSG00000029867). The
identity of bull, hamster, human, and rat SOF1 compared to
mouse SOF1 is 62%, 70%, 49%, and 76%, respectively (SI
Appendix, Fig. S2A). SOF1 contains the conserved sequence
motifs “LLLL” and “CFN(L or S)AS” in these species, but the
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Fig. 1. Fertility of Sof1 del/del mice. (A) Multitissue gene expression by RT-
PCR analysis. Mouse Sof1 is abundantly expressed in a testis. Beta actin
(Actb) was used as the control. Br, brain; Th, thymus; Lu, lung; He, heart; Li,
liver; Sp, spleen; Ki, kidney; Te, testis; Epi, epididymis; Cap, caput epididymis;
Cor, corpus epididymis; Cau, cauda epididymis; SV, seminal vesicle; Pr,
prostate; Ov, ovary; Ut, uterus. (B) Detection of Sof1 mRNA in testes post-
natally. Mouse Sof1 was detected in testis after postnatal day 28. (C) De-
tection of SOF1 in TGC and spermatozoa. TGC and spermatozoa of wild-type
(wt) and Sof1 whole deletion (del) males (SI Appendix, Fig. S2) were used for
Western blot analysis. Specific bands were detected in WT TGC and sper-
matozoa (red arrows). (D) Male fecundity. Each male was caged with twowt/
wt females for 2 mo. Sof1 del/del males succeeded in mating, but females
did not deliver any offspring (pups/plug: 7.9 ± 2.8 [del/wt], 0 [del/del]). The
litter sizes of Sof1 del/wt and del/delmales were 9.6 ± 1.2 and 0, respectively.
(E) Sperm fertilizing ability with cumulus-intact oocytes in vitro. Fertilized
eggs with two PN (2 PN) (asterisks) were observed in Sof1 control sperma-
tozoa (Upper). However, Sof1 KO spermatozoa were accumulated in the
perivitelline space (arrowheads, Upper), and there were no oocytes bearing
2 PN (Lower, fertilization rates: 99.5 ± 0.9% [wt/wt, 153 oocytes], 97.3 ±
4.6% [del/wt, 159 oocytes], 0% [del/del, 375 oocytes]) (Movie S3). (F) Sperm−
oocyte fusion assay. Spermatozoa were incubated with the ZP-free oocytes
prestained with Hoechst 33342 for 30 min. Sof1 control spermatozoa were
stained by Hoechst 33342, indicating that they fused with oocytes (arrows).
Sof1 KO spermatozoa bound to the oolemma, but Hoechst 33342-positive
spermatozoa were rarely observed in the Sof1 KO group (Hoechst
33342-positive spermatozoa/oocyte: 1.12 ± 0.36 [wt/wt, n = 5, 110 oocytes],
0.06 ± 0.07 [del/del, n = 5, 119 oocytes], P < 0.01). Two mutant lines (d1024
and d1039; SI Appendix, Fig. S1) were used for this assay. (G) Sperm fertil-
izing ability with ZP-free oocytes in vitro. Sof1 KO spermatozoa could not
fertilize oocytes (fertilization rates: 100% [wt/wt, n = 3, 50 oocytes], 0% [del/
del, n = 3, 64 oocytes]).
































To examine the physiological function of SOF1, we generated
Sof1 mutant mice by introducing a guide RNA (gRNA)/Cas9
expression vector into oocytes (for indel) and embryonic stem
(ES) cells (for deletion) (SI Appendix, Fig. S2B and Table S2).
We established three mutant lines carrying 1-base pair (bp)
(endonuclease-mediated mutation [em] 1), 1,024-bp (em2), or
1,039-bp (em3) deletions (SI Appendix, Fig. S2 C–E). As mice
lacking 1,024 bp and 1,039 bp delete the SOF1 ORF, these mice
were used for subsequent analyses. SOF1 is detected in testicular
germ cells (TGC) and spermatozoa of wild-type (wt) mice, but
these bands disappear in Sof1 gene deletion (del)/del mice
(Fig. 1C). We could not obtain fertilized eggs from females
mated with Sof1 del/del males (SI Appendix, Fig. S2F and Movies
S1 and S2). Further, when Sof1 del/del males were caged with
wt/wt females for 2 mo, the males failed to sire offspring (Fig. 1D).
In contrast, Sof1 del/del females are fertile. There was no dif-
ference in the fertilizing ability between Sof1 del/del (em2)
and Sof1 del/del (em3) males in vivo, and we therefore used Sof1
del/del (em2) for the subsequent experiments, unless otherwise
specified.
Sof1 KO Spermatozoa Exhibit Defective Fusion Ability with Oolemma.
To reveal the cause of the male sterility, we first analyzed
spermatogenesis of Sof1 mutant males. There was no difference
in the testis morphology and weights between Sof1 del/wt and del/
del males (SI Appendix, Fig. S3 A and B). We could not observe
any overt defects in spermatogenesis of Sof1 del/del males (SI
Appendix, Fig. S3C). The morphology of Sof1 KO spermatozoa is
normal, and the motility parameters of Sof1 KO spermatozoa are
comparable to control spermatozoa, by computer-assisted sperm
analysis (CASA) (SI Appendix, Fig. S3 D and E). When Sof1
mutant spermatozoa were used for in vitro fertilization (IVF)
with cumulus-intact oocytes, Sof1 KO spermatozoa could pene-
trate the ZP, but they accumulated in the perivitelline space
(Fig. 1 E and Movie S3). Sof1 KO spermatozoa could not fer-
tilize oocytes (Fig. 1 E). To analyze the cause of sperm accu-
mulation in the perivitelline space, we examined sperm−oocyte
fusion ability using ZP-free oocytes. Although Sof1 KO sper-
matozoa bound to the oocyte membrane (number of sperm
bound/oocyte: 7.6 ± 3.4 [control], 9.0 ± 4.4 [Sof1 KO]), we rarely
observed fused spermatozoa by staining with Hoechst 33342
(Fig. 1F). Consistently, ZP-free oocytes incubated with Sof1 KO
spermatozoa were not fertilized (Fig. 1G). Thus, Sof1 KO
spermatozoa cannot fuse with the oocyte membrane, causing the
male sterility. To interrogate whether the defective fusion ability
was attributed to the disruption of IZUMO1, we examined the
amount and localization of IZUMO1 in Sof1 KO spermatozoa.
The signal intensity of IZUMO1 in Sof1 KO spermatozoa was
comparable to control spermatozoa (Fig. 2A), and we could not
observe overt defects in IZUMO1 localization in Sof1 KO
spermatozoa before and after the acrosome reaction (Fig. 2B).
We next examined whether SOF1 remains in acrosome-reacted
spermatozoa. We incubated spermatozoa in Toyoda–Yokoyama–
Hosi (TYH) drops containing Ca2+ ionophore A23187 for 1 h to
induce acrosome reaction, and these spermatozoa were subsequently
subjected to immunostaining. Almost all of spermatozoa were dem-
onstrated to be acrosome-reacted by IZUMO1 staining (Fig. 2C).
The sperm extracts were probed with an anti-SOF1 antibody. Both
forms of SOF1 decreased in A23187-treated spermatozoa, but the
upper form remained (Fig. 2D); see Discussion.
Sterility of Sof1 del/del Male Mice Is Rescued by a Transgene. To
confirm that the Sof1 disruption is responsible for the phenotype,
we generated Tg mice in which mouse SOF1 with a PA tag were
expressed using the testis-specific Clgn promoter (SI Appendix,
Fig. S2 G and H) on the Sof1 del/del background. When Tg-
positive Sof1 del/del males were mated with wt/wt females, we
could collect two pronuclei (PN; fertilized) eggs and obtain
offspring (Fig. 2 E and F). Thus, the Clgn-Sof1 transgene rescued
the defect and confirms that SOF1 is required for sperm−oocyte
fusion and male fertility.
Tmem95 del/del Males Are Sterile. As depicted by RT-PCR analy-
ses (using primers as shown in SI Appendix, Table S1), Tmem95
was exclusively expressed in mouse testis, and testis expression
was first observed on day 21 postpartum, during which sper-
miogenesis initiates (Fig. 3 A and B). Such a pattern of postnatal























































Fig. 2. Characterization of Sof1 KO spermatozoa and Tg rescue. (A) De-
tection of IZUMO1 in spermatozoa. IZUMO1 was detected in Sof1 control
and KO spermatozoa at a comparable level. BASIGIN, a sperm tail protein,
was used as a loading control. (B) Immunostaining of IZUMO1 in sperma-
tozoa before and after the acrosome reaction. After the acrosome reaction,
IZUMO1 in Sof1 KO spermatozoa spread out over the entire head (arrow-
heads), indicating that the IZUMO1 localization of Sof1 KO spermatozoa is
normal. (C) Inducement of sperm acrosome reaction using Ca2+ ionophore
A23187. To examine acrosome reaction rates, spermatozoa were stained
with an anti-IZUMO1 antibody. DMSO was used as the control. Acrosome
reaction rates of spermatozoa treated with DMSO and A23187 were 19.7 ±
10.8% (n = 4) and 83.3 ± 5.5% (n = 4), respectively. (D) Detection of SOF1 in
A23187-treated spermatozoa. The doublet bands of SOF1 were detected in
spermatozoa treated with DMSO. The lower band disappeared in A23187-
treated spermatozoa, but the upper band remained. There was no signifi-
cant difference in the amount of IZUMO1 between DMSO- and A23187-
treated spermatozoa, in agreement to the previous report (10). BASIGIN
and SLC2A3, which are mainly localized in sperm tail, were used as the
control. (E) Oocyte observation of females mated with Sof1 del/del males
having the Sof1-PA Tg insertion. Sof1 KO spermatozoa were accumulated in
the perivitelline space (arrowheads), but spermatozoa of Sof1-PA Tg rescued
Sof1 del/del males (del/del; Tg) could fertilize oocytes (asterisks) (2 PN rates:
0% [del/del, 109 oocytes, n = 3], 100% [del/del; Tg, 39 oocytes, n = 3]). (F)
Male fecundity of Sof1-PA Tg rescue mice. Each male was caged with two
wt/wt females for more than 1 mo. The females mated with Sof1-PA
Tg rescue males could deliver offspring (pups/plug: 0 [del/del], 8.7 ± 1.8
[del/del; Tg]). The litter sizes of Sof1 del/del and Sof1-PA Tg rescue males
were 0 and 10.2 ± 0.5, respectively. The data of fecundity in Sof1 del/del
males were reused data of Fig. 1D.













































the aforementioned scRNA-seq data, in which the mRNA ex-
pression peaks at the mid-spermatid stage in human but is below
the level of detection in mouse (SI Appendix, Fig. S1). Tmem95 is
widely conserved, and its protein sequences show a high simi-
larity among mammalian species, such as bull, hamster, human,
mouse, and rat (SI Appendix, Fig. S4A). To generate Tmem95
KO mice, two gRNAs were designed to target the 5′ region
upstream of the first exon and 3′ untranslated region (UTR) of
Tmem95 locus (SI Appendix, Fig. S4B). The mouse line was
generated by introducing CRISPR RNA (crRNA)/trans-
activating crRNA/Cas9 ribonucleoprotein complexes into two
PN mouse zygotes via electroporation. Tmem95 wt/wt, del/wt, and
del/del mice were distinguished by genomic PCR using forward
and reverse primers targeting the 5′ and 3′ regions of Tmem95,
respectively (SI Appendix, Fig. S4 B and C and Table S2). Sanger
sequencing of the KO allele indicated that the mutant mice carry
a 1,919-bp deletion in the Tmem95 locus (SI Appendix, Fig. S4D).
By pairing male mice consecutively with wt/wt females for 10 wk,
we discovered that the del/del males fail to sire any offspring,
despite an observation of 43 copulation plugs during the mating
period. The wt/wt pairs that served as a positive control gave an
average litter size of 10.2 ± 1.9 (Fig. 3C). The fecundity of del/del
females was unaffected, as demonstrated by normal litter sizes
observed from mating between Tmem95 del/wt males and del/del
females. To investigate whether absence of Tmem95 leads to
pathological abnormalities in the male reproductive system, the
gross appearance and histological sections of testes and epidid-
ymides and the morphology and motility of spermatozoa from
del/del males were observed in parallel with analyses of tissues
and specimens from del/wt littermates. However, the testis ap-
pearance, size, and weight in del/del males are comparable to
heterozygotes (SI Appendix, Fig. S5 A and B). No distinct dif-
ference or abnormality was observed in the composition, quan-
tity, and morphology of spermatogenic cells in the seminiferous
tubules at each stage and spermatozoa in the caput and cauda
epididymides (SI Appendix, Fig. S5C). Tmem95 KO spermatozoa
showed normal morphology (SI Appendix, Fig. S5D) and normal
motility as determined by CASA (SI Appendix, Fig. S5 E and F).
Tmem95 KO Spermatozoa Exhibit Impaired Fusion Ability with
Oolemma. Since Tmem95 del/del males show normal sperm pro-
duction and behavior, IVF analysis was conducted to further
understand the cause of the male sterility. After 6 h of in-
semination, KO spermatozoa were unable to fertilize WT oocytes
and accumulated in the perivitelline space (Fig. 3 D, Upper and
Movie S4). In comparison, ∼97% of oocytes were fertilized by
control spermatozoa, as reflected by formation of two PN
(Fig. 3D). Because membrane fusion ability of Tmem95 KO
spermatozoa might be compromised by depletion of Tmem95, a
fusion assay was performed using Hoechst 33342-preloaded ZP-
free oocytes. Control spermatozoa could fuse with the plasma
membrane of oocytes, as indicated by the transfer of Hoechst
33342 signal to the internalized sperm heads. Although the
binding index of Tmem95 KO spermatozoa to the oocyte surface
(8.7 ± 1.3 spermatozoa per oocyte) was comparable to that of
control spermatozoa (9.8 ± 1.5 spermatozoa per oocyte), the KO
spermatozoa could rarely fuse with the oocyte membrane, as
shown (Fig. 3E). The average numbers of control and KO sper-
matozoa that fused to the oocyte membrane were 1.09 ± 0.03 and
0.17 ± 0.02, respectively. To further verify the inability of Tmem95
KO spermatozoa to fuse with the oocyte plasma membrane, IVF
analysis was conducted using ZP-free oocytes. After 6 h of in-
semination, about 89% of ZP-free oocytes were fertilized by
control spermatozoa, whereas no oocytes were found to be fer-
tilized by KO spermatozoa (Fig. 3F).
To explore the probability that the fusion defect originated
from impaired functioning of IZUMO1, protein amount and


















































































































































Fig. 3. Analyses of Tmem95 del/del male mice. (A) Detection of Tmem95
mRNA in mouse tissues and organs by RT-PCR. (B) Detection of Tmem95
mRNA in mouse testes postnatally. (C) Analysis of the fecundity of Tmem95
del/del males by mating tests. Males were caged with wt/wt females for 10
wk, during which copulation plugs were examined and litter sizes were
recorded. The wt/wt males were examined in the meantime as a positive
control. During the mating test, while the wt/wt mating pairs delivered 337
offspring with an average litter size of 10.2 ± 1.9, the del/del males sire no
pup. (D) IVF analysis of the ability of Tmem95 KO spermatozoa to fertilize
cumulus-intact oocytes. (Upper) After 6 h of incubation, Tmem95 control
spermatozoa successfully inseminated oocytes indicated by the formation of
2 PN (asterisks), whereas the KO spermatozoa were accumulated in the
perivitelline space and cannot fertilize the oocytes (arrowheads). (Lower)
The control spermatozoa give a high fertilization rate of about 97%. In
contrast, no 2 PN eggs were observed when inseminated with the KO
spermatozoa. (E) Analysis of the ability of Tmem95 KO spermatozoa to fuse
with the oocyte plasma membrane. Spermatozoa were incubated with
Hoechst 33342-preloaded oocytes for 30 min, and the membrane fusion was
determined by the transfer of Hoechst 33342 fluorescence signal to fused
sperm heads (yellow arrows). The lower bright-field images indicate both
Tmem95 control and KO spermatozoa could bind normally to the oocyte
surface. (F) IVF analysis of the ability of Tmem95 KO spermatozoa to fuse
with ZP-free oocytes. While about 97% of the Tmem95 control sperm-
inseminated oocytes formed 2 PN, the KO spermatozoa could not fuse
with ZP-free oocytes at all. (G) Expression of IZUMO1 in Tmem95 KO sper-
matozoa. The expression of IZUMO1 was comparable in the testis and sperm
lysates of Tmem95 del/wt and del/del males. The expression of BASIGIN was
analyzed in parallel by immunoblotting as a loading control. (H) Localization
of IZUMO1 in Tmem95 KO spermatozoa before and after the acrosome re-
action. After 10 and 120 min of incubation in TYH medium, the localization
of IZUMO1 in the control and KO spermatozoa was visualized by immuno-
cytochemistry. Sperm nuclei were labeled by Hoechst 33342. Same as control
sperm, IZUMO1 in the KO spermatozoa was localized to the acrosome cap
before the acrosome reaction and translocated to the equatorial segment or
the entire sperm head after the acrosome reaction.
































immunocytochemistry, respectively. As shown in Fig. 3G, the
amount of IZUMO1 protein was equally detected in testis and
sperm lysates of del/wt and del/del males. In addition, the local-
ization of IZUMO1 was examined in both control and KO
spermatozoa after 10 and 120 min of incubation in TYH me-
dium. Similar to control spermatozoa, IZUMO1 localized to the
acrosome cap in the acrosome-intact KO spermatozoa and
relocated to the equatorial segment or the entire sperm head of
acrosome-reacted KO spermatozoa (Fig. 3H). The translocation
of IZUMO1 indicated that IZUMO1 functioned normally in
Tmem95 control and KO spermatozoa, and the spermatozoa
could undergo a normal acrosome reaction. Thus, defective fu-
sion ability of Tmem95 KO spermatozoa was not ascribed to the
dislocation or dysfunction of IZUMO1.
Infertility of Tmem95 del/del Mice Is Restored by a Transgene. To
confirm that the impaired sperm fusion ability in Tmem95 KO
spermatozoa originated from the removal of Tmem95, Tg mice
expressing 1D4-tagged TMEM95 were generated (SI Appendix,
Fig. S6 A and B). Tmem95 del/del females that had been paired
with a Tmem95 del/del; Tg male mouse delivered 31 offspring in
four litters (7.8 ± 0.5 pups per litter; SI Appendix, Fig. S6C),
indicating that the KO phenotype was rescued by the transgene.
When pairing Tmem95 del/del; Tg males with hormone-treated
wt/wt females, a high fertilization rate of 94.4% ± 4.4% was
observed (n = 3). Immunoblot analysis detected expression of
the TG protein in both Tg testis and spermatozoa. Localization
of TMEM95 could not be determined by immunostaining,
probably due to the low level of expression of the TG protein in
Tg spermatozoa (yellow arrowhead; SI Appendix, Fig. S6D).
Spaca6 del/del Male Mice Are Sterile. Spaca6 has been previously
suggested to be involved in membrane fusion between sperma-
tozoa and oocytes in mice (34). The expression of Spaca6mRNA
exhibits a strong bias toward the testis, as determined by RT-
PCR analysis using complementary DNA (cDNA) extracted
from multiple mouse tissues and organs (primers as shown in SI
Appendix, Table S1). Minor expression was also detected in the
epididymis, seminal vesicle, and ovary (Fig. 4A). In corrobora-
tion with the expression pattern obtained from the scRNA-seq
analysis of spermatogenic cells, the expression of Spaca6 mRNA
was initially detected on postnatal day 21, the onset of sper-
miogenesis (Fig. 4B). Similar to other fusion-related sperm
proteins, the in silico prediction indicated that Spaca6 exhibits
peak mRNA expression at the mid-round spermatid stage in
both humans and mice (SI Appendix, Fig. S1).
Distinct from Sof1 and Tmem95, Spaca6 showed a broader
range of evolutionary conservation, according to various public
databases; orthologs of SPACA6 have been annotated not only
in mammals (e.g., bull, hamster, human, mouse, and rat) but also
in nonmammalian vertebrates such as fish (e.g., zebrafish) with
less homology (SI Appendix, Fig. S7A). Based on public data-
bases such as UniProt and Simple Modular Architecture Re-
search Tool (SMART), SPACA6 displays similar domain
structures compared with IZUMO1. Both proteins have a short
signal peptide of about 20 amino acids (aa) at the N termini, an
Ig-like domain of about 85 aa, an N-linked glycosylation site
upstream of a type I transmembrane domain of 20 aa, and a
short cytosolic tail at the C terminus (SI Appendix, Fig. S7B).
The Spaca6 del/del mouse line was generated by zygote elec-
troporation of Cas9 and gRNAs targeting the first coding exon
and the region downstream of the 3′ UTR (SI Appendix, Fig.
S7C). The KO and wt alleles were identified by genomic PCR
using primers targeting the 5′ and 3′ regions of Spaca6 and pri-
mers flanking the first exon, respectively (SI Appendix, Fig. S7 C
and D and Table S2). Mutant mice bearing an 8,085-bp deletion
and a 4-bp insertion were validated by Sanger sequencing of the
mutated locus (SI Appendix, Fig. S7E). Mating tests indicated
that Spaca6 del/del males could not sire any offspring when caged
with wt/wt females for 10 wk, despite producing 35 vaginal plugs
during the mating period. In contrast, the average litter size
obtained from the wt/wt breeding pairs was 8.8 ± 2.4 (Fig. 4C).
Although there is a trace amount of Spaca6mRNA expression in
the ovary, depletion of Spaca6 did not cause any adverse effect
on female fecundity, as demonstrated by normal numbers of
offspring obtained per litter from pairing Spaca6 del/wt males
with del/del females.
Phenotypic analyses were carried out to investigate whether
the infertility of Spaca6 del/del males was derived from abnor-
malities in the male reproductive system. Testis appearance, size,
and weight in del/del males were normal compared to their del/wt
littermates (SI Appendix, Fig. S8 A and B). The del/del males




















































































































Fig. 4. Analyses of Spaca6 del/del male mice. (A) Detection of Spaca6mRNA
in various mouse tissues and organs by RT-PCR. (B) Detection of Spaca6
mRNA in mouse testes at various postnatal days by RT-PCR. (C) Analysis of
the fecundity of Spaca6 del/del males by mating tests. Males were caged
withwt/wt females for 10 wk, during which copulation plugs were examined
and litter sizes were recorded. The wt/wt males were examined, in the
meantime, as a positive control. While the wt/wt mating pairs delivered 264
offspring with an average litter size of 8.8 ± 2.4, the del/del males failed to
sire offspring. (D) IVF analysis of the ability of Spaca6 KO spermatozoa to
fertilize cumulus-intact oocytes. (Upper) After 6 h of incubation, Spaca6
control spermatozoa successfully inseminated oocytes indicated by the for-
mation of 2 PN (asterisks), whereas the KO spermatozoa were accumulated
in the perivitelline space and cannot fertilize the oocytes (yellow arrow-
heads). (Lower) The control spermatozoa gave a high fertilization rate of
about 97%. In contrast, no 2 PN eggs were observed when incubated with
KO spermatozoa. (E) Analysis of the ability of Spaca6 KO spermatozoa to
fuse with the oocyte plasma membrane. Spermatozoa were incubated with
Hoechst 33342-preloaded oocytes for 30 min, and the membrane fusion was
determined by transfer of Hoechst 33342 fluorescence signal to fused sperm
heads (yellow arrows). The lower bright-field images indicate both control
and KO spermatozoa could bind normally to the oocyte surface. (F) IVF
analysis of the ability of Spaca6 KO spermatozoa to fuse with ZP-free oocytes.
While about 97% of the control sperm-inseminated oocytes formed 2 PN, KO
spermatozoa could not fuse with ZP-free oocytes.













































(SI Appendix, Fig. S8C), normal sperm morphology (SI Appendix,
Fig. S8D), and normal sperm motility (SI Appendix, Fig. S8
E and F).
Spaca6 KO Spermatozoa Exhibit Impaired Fusion Ability with
Oolemma. The function of Spaca6 KO spermatozoa was further
interrogated by IVF to uncover the cause of the male sterility.
After 6 h of incubation in TYH medium, over 98% of the
cumulus-intact oocytes were successfully fertilized by Spaca6
control spermatozoa, as indicated by the presence of two PN. In
contrast, no embryos were observed when inseminated with KO
spermatozoa (Fig. 4D). Similar to the aforementioned Sof1 and
Tmem95 KO spermatozoa, Spaca6 KO spermatozoa accumu-
lated in the perivitelline space of WT oocytes (Movie S5), in-
dicating that the KO spermatozoa were able to penetrate the ZP
but could not fuse with the oocyte plasma membrane (Fig. 4D).
Thus, a sperm−oocyte fusion assay was carried out to investigate
the ability of Spaca6 KO spermatozoa to fuse with the oocyte
membrane. Similar to control spermatozoa (8.3 ± 1.7 sperma-
tozoa per oocyte), KO spermatozoa could adhere to the oocyte
surface with a binding index of 8.4 ± 2.7 spermatozoa per oocyte.
However, Spaca6 KO spermatozoa were rarely found to fuse
with the oocyte plasma membrane (Fig. 4E). The average
numbers of control and KO spermatozoa fused with the oocyte
plasma membrane were 1.6 ± 0.13 and 0.07 ± 0.07, respectively.
According to the IVF analysis, ∼96% of the WT ZP-free oocytes
were fertilized by control spermatozoa, while no fertilized eggs
were observed in the Spaca6 KO sperm-inseminated group
(Fig. 4F).
Immunoblotting and immunocytochemistry were further
employed to assess the amount and localization of IZUMO1 in
Spaca6 KO spermatozoa. IZUMO1 was equally existed in testis
and spermatozoa of del/wt and del/del males (Fig. 5A), and
IZUMO1 localization was normal in both acrosome-intact and
reacted KO spermatozoa (Fig. 5B).
Sterility of Spaca6 del/del Male Mice Is Rescued by a Transgene. To
further characterize the behavior and possible function of
SPACA6 during sperm−oocyte fusion, a Tg mouse line expressing
1D4-tagged SPACA6 was generated (SI Appendix, Fig. S9 A and B
and Table S3). As shown in Fig. 5C, 1D4-tagged SPACA6 was
observed in both testis and sperm lysates, whereas no signal was
detected in the testis or spermatozoa of del/wt males that did not
carry the transgene. When Spaca6 del/del; Tg males were paired
with hormone-treated wt/wt females, 90.9% ± 2.7% of the oocytes
were fertilized similar to control males (89.7 ± 10.2%; Fig. 5D and
SI Appendix, Fig. S9C). In addition, housing of Spaca6 del/del;
Tg males with WT females for 6 wk resulted in normal litter sizes
(8.7 ± 0.1 [n = 4 males]; 15 plugs; 15 litters; 130 total offspring).
These results indicate that the 1D4-tagged SPACA6 rescued the
impaired fusion ability of KO spermatozoa. The localization of
1D4-tagged SPACA6 was subsequently visualized by immunocy-
tochemistry. The tagged SPACA6 was localized to the acrosome
cap before the acrosome reaction and translocated to the equa-
torial segment after the acrosome reaction (Fig. 5E). To in-
vestigate whether SPACA6 could interact with IZUMO1,
coimmunoprecipitation (co-IP) was performed using testis lysates
from del/wt males with or without transgene. IZUMO1 was not
detected in the protein complex precipitated using anti-1D4
antibody-conjugated magnetic beads (Fig. 5F), suggesting that
IZUMO1 did not form a complex with SPACA6 in the testis.
SOF1, TMEM95, and SPACA6 Are Conserved in Mammals. We exam-
ined the conservation of SOF1, TMEM95, and SPACA6 among
species using TreeFam (http://www.treefam.org/). TreeFam is a
database indicating the phylogenetic trees predicted from animal
genomes. This software also provides orthology/paralogy pre-
dictions as well as the evolutionary histology of genes (36). These
genes were rarely conserved in animal species, such as flies,
frogs, and birds, but they were widely conserved in mammals






















































































































Fig. 5. Analyses of Spaca6-1D4 Tg male mice. (A) Expression of IZUMO1 in
Spaca6 KO spermatozoa. The expression of IZUMO1 was comparable in the
testis and sperm lysates of del/wt and del/del males. The expression of
BASIGIN was analyzed in parallel by immunoblot analysis as a loading con-
trol. (B) Localization of IZUMO1 in Spaca6 KO spermatozoa before and after
the acrosome reaction. After 10 and 120 min of incubation in TYH medium,
the localization of IZUMO1 in control and KO spermatozoa was visualized by
immunocytochemistry. Sperm nuclei were labeled by Hoechst 33342. Same
as control spermatozoa, IZUMO1 in Spaca6 KO spermatozoa was localized to
the acrosome cap before acrosome reaction and translocated to the equa-
torial segment or the entire sperm head after acrosome reaction. (C) Ex-
pression of SPACA6-1D4 in testes and cauda epididymal spermatozoa of Tg
male mice. Testis and sperm lysates from del/wt; Tg males (del/wt; Tg) were
used to test Tg expression. HEK293T cells expressing SPACA6-1D4 were an-
alyzed as a positive control, and the testis and sperm lysates from del/wt
males were used as a negative control. The expression of ACTB and BASIGIN
was analyzed in parallel as loading controls for the immunoblotting of
HEK293T lysates and testis/sperm lysates, respectively. (D) Analysis of the
fecundity of Spaca6 del/del; Tg males expressing SPACA6-1D4. Male mice
were paired with hormone-treated wt/wt females, and oocytes were har-
vested from the females about 9 h after copulation. Spaca6 wt/wt and del/
del males were analyzed as positive and negative controls, respectively. The
fecundity of two Spaca6 del/del; Tg males were tested twice each (for a total
of four trials). (E) Localization of SPACA6-1D4 in the spermatozoa of Tg mice
before and after the acrosome reaction. After 10 and 120 min of incubation
in TYH medium, the localization of SPACA6-1D4 in the spermatozoa of del/
wt; Tg males was visualized by immunocytochemistry. Spermatozoa from
del/wt males were analyzed in parallel as a negative control. The sperm
nuclei were labeled by Hoechst 33342. SPACA6 was localized to the acro-
some cap before acrosome reaction and spread out toward the equatorial
segment after acrosome reaction. (F) Co-IP and Western blot analysis of the
interaction between IZUMO1 and SPACA6. Testis lysate from del/wt; Tg
males was incubated with anti-1D4 antibody-conjugated magnetic beads,
and the eluted protein complex was separated by SDS/PAGE and analyzed by
Western blot analysis. IZUMO1 was not detected in the co-IP product.
































livestock (e.g., pig and cow), and primates, including human (SI
Appendix, Fig. S10). These results are similar to the phylogenetic
trees of FIMP and IZUMO1 (Fig. 6A and SI Appendix, Fig. S10).
Thus, Sof1, Tmem95, and Spaca6 emerged as fusion-related
genes in gametes during evolution.
In Vitro Cell-Based Assays Depicted Codependency of Fusion-Related
Proteins. To assess potential interactions between IZUMO1 and
other fusion-related proteins, co-IP was carried out using the
lysates of HEK293T cells coexpressing IZUMO1 and each of the
other fusion-related proteins. IZUMO1 was found to interact
with SOF1 (SI Appendix, Fig. S11A), TMEM95, SPACA6 (SI
Appendix, Fig. S11B), and FIMP (SI Appendix, Fig. S11C) in
HEK293T cells. ADAM1B, a protein that localizes to the sperm
surface and is not involved in sperm−oocyte fusion, was analyzed
as a negative control and failed to interact with IZUMO1 as
expected (SI Appendix, Fig. S11D).
Previous studies demonstrated that transient expression of
recombinant mouse IZUMO1 in cultured cells, such as HEK293T
and Cos-7 cells, endows them with strong binding affinity to the
surface of ZP-free oocytes (17). As expected, HEK293T cells
overexpressing IZUMO1-mCherry bound to the ZP-free oocytes
with a binding index of 3.3 ± 1.3 cells per oocyte (Fig. 6B). Nev-
ertheless, HEK293T cells expressing SOF1-1D4, TMEM95-1D4,
or SPACA6-1D4 barely bind to ZP-free oocytes (Fig. 6B). Coex-
pression of IZUMO1-mCherry, SOF1-1D4, TMEM95-1D4,
SPACA6-1D4, and FIMP-FLAG in HEK293T cells allowed the
cells to bind to but not fuse with the oocyte membrane (Fig. 6C).
Cultured cells overexpressing all of these proteins except for
IZUMO1-mCherry failed to bind to ZP-free oocytes. Further, the
binding index of HEK293T cells expressing all fusion proteins
(4.0 ± 0.6 cells per oocyte) was comparable to that of the ones
solely expressing IZUMO1 (3.5 ± 0.2 cells per oocyte), implying
that coexpression of the other four proteins could not promote
IZUMO1-derived membrane adhesion in vitro (Fig. 6C). Ex-
pression of the recombinant proteins in HEK293T cells was
confirmed by immunoblot analysis and immunostaining (SI Ap-
pendix, Fig. S12).
Discussion
Mammalian fertilization has been studied for decades, and re-
searchers in the field have tried to discover essential factors to
elucidate the molecular mechanisms underlying sperm−oocyte
fusion (1). While a combination of IVF and fusion-inhibiting
antibodies had nominated critical proteins, IZUMO1 was, until
now, the only sperm protein proven to be essential by KO mouse
studies (2, 4). Recently, by making KO mice using the CRISPR-
Cas9 system, we identified sperm protein FIMP as a sperm−oocyte
fusion-related protein (31). Specifically, FIMP localizes to the
equatorial segment of acrosome-intact spermatozoa, and a faint
signal remains after the acrosome reaction in some spermatozoa.
Surprisingly, the amount and localization of IZUMO1 in FimpKO
spermatozoa were not influenced. Because IZUMO1 and FIMP
fail to show fusogenic features, more factors need to be discovered
to elucidate the sperm−oocyte fusion process. In the present study,
we demonstrate that testis-enriched proteins SOF1, TMEM95,
and SPACA6 are essential for sperm−oocyte fusion in mice.
SOF1 was detected as a protein singlet and a doublet in TGCs
and acrosome-intact spermatozoa, respectively (Fig. 1C), sug-
gesting SOF1 undergoes posttranslational modification during
sperm maturation. The upper band of SOF1 remains whereas
the lower band disappears after the acrosome reaction (Fig. 2D).
Recombinant expression of SOF1 in HEK293T cells also ap-
pears as a protein doublet (SI Appendix, Fig. S11). These findings
imply that 1) the upper form that remains in acrosome-reacted
spermatozoa functions during gamete fusion or 2) the lower
form is released from sperm surface during acrosomal exocytosis
to activate or unmask other fusion-inducing factors. Future char-
acterization of SOF1 is necessary to unveil its detailed functions.
Similar to IZUMO1 and SPACA6 (9, 34), TMEM95 is also
identified as a type I single-pass transmembrane protein carrying
a signal peptide at the N terminus and a transmembrane helix
near its C terminus. It has been reported that a nonsense mu-
tation in TMEM95, which induces truncation at the trans-
membrane region, leads to idiopathic subfertility in bulls (32).
Bovine spermatozoa bearing the mutant TMEM95 are able to
undergo the acrosome reaction but show impaired ability to fuse
with the oocyte plasma membrane. Hence, the transmembrane
domain may be important for the normal functioning of
TMEM95 in underpinning sperm−oocyte fusion. The necessity
of the transmembrane domain in fusion-related sperm factors
has also been demonstrated in FIMP (31). The impaired fusion
ability of Fimp KO spermatozoa is restored by Tg expression of
the membrane isoform of FIMP.
As reported previously, TMEM95 is localized to the acrosome
cap of the bull spermatozoa before acrosome reaction. In-













































































































































Fig. 6. Phylogenetic analyses of the fusion-related sperm proteins and
binding assays between ZP-free oocytes and HEK293T cells overexpressing
the fusion proteins. (A) Phylogenetic trees of FIMP, IZUMO1, SOF1, SPACA6,
and TMEM95 using TreeFam. The presence of orthologs is indicated by dark
green. Light green indicates loss of an ortholog in several species within a
taxon. (B) Comparison of oocyte binding ability of HEK293T cells individually
expressing recombinant IZUMO1, SOF1, SPACA6, and TMEM95. ZP-free oocytes
were incubated with Hoechst 33342-preloaded HEK293T cells overexpressing
different fusion-related sperm proteins. Only HEK293T cells expressing IZUMO1-
mCherry could adhere to the ZP-free oocytes. (C) Comparison of oocyte binding
ability of HEK293T cells simultaneously overexpressing various fusion-related
sperm factors. HEK293T cells expressing all factors except for IZUMO1 (shown
as No IZUMO1) cannot bind to the oocyte surface. No significant (N.S.) differ-
ence was observed between the binding indexes of the cells overexpressing all
of the five factors and IZUMO1 only.













































spermatozoa (33). The removal of this protein during acrosome
exocytosis implies that it may serve functions that are completely
different from IZUMO1. TMEM95 may not act as a fusogenic
protein that directly mediates the membrane fusion between
spermatozoa and oocytes. Instead, it may mask the real fusogens
that mediate sperm−oocyte membrane fusion before the acro-
some reaction; the release of TMEM95 may facilitate the func-
tional domain of the fusogenic protein to be exposed to the cell
surface, which is required for fusion to occur. Alternatively, it is
possible that sperm−oocyte membrane fusion is a bilateral fusion
process, where the fusogen needs to be presented on both
membranes; during acrosomal exocytosis, TMEM95 may be re-
leased and transferred to the oocyte plasma membrane, thereby
ensuring fusion to occur bilaterally.
SPACA6 has been reported years ago as a sperm protein that
may be required for sperm−oocyte membrane fusion (34).
However, little attention has been given to this protein by re-
searchers in the field, and the mechanism underlying this fusion-
related factor remains unknown. Although the peptide se-
quences of SPACA6 and IZUMO1 barely share homology,
profound similarities are identified between their domain com-
positions (SI Appendix, Fig. S7B). Thus, it is tempting to spec-
ulate that SPACA6 would exhibit IZUMO1-like function and
behavior during fertilization. Utilizing a Tg mouse line express-
ing 1D4-tagged SPACA6, we localized SPACA6 in the sperma-
tozoa before and after the acrosome reaction. Similar to
IZUMO1 and TMEM95, SPACA6 initially localizes to the ac-
rosome cap in acrosome-intact spermatozoa.
Distinct from IZUMO1, which is stochastically translocated to
the equatorial segment or the entire sperm head after the ac-
rosome reaction, SPACA6 spreads out only to the equatorial
segment in acrosome-reacted spermatozoa. This relatively
stringent translocation of SPACA6 may explain why membrane
fusion usually occurs at the equatorial segment of spermatozoa
(10). Although Tg expression of tagged SPACA6 facilitates the
determination of the subcellular localization of this protein, the
fluorescence signal of SPACA6-1D4 in the spermatozoa is very
weak, which is in concert with the weak band of SPACA6-1D4
detected in sperm lysate by immunoblot analysis (Fig. 5C).
Whether the low protein amount reflects the behavior of en-
dogenous SPACA6 or is due to unstable Tg expression can be
clarified in future studies utilizing a good antibody against
mouse SPACA6.
Notwithstanding the structural similarities between IZUMO1
and SPACA6, no interaction was detected between these two
proteins by co-IP tandem immunoblot analysis of testis extracts
(Fig. 5F). However, co-IP analyses using HEK293T cells dem-
onstrated interactions between IZUMO1 and all other known
fusion-related proteins (SI Appendix, Fig. S11). In spermatozoa,
such protein−protein interactions might be transiently estab-
lished after IZUMO1 translocation upon acrosome reaction, or
even after IZUMO1 binds to JUNO. Thus, it would be difficult
to detect such interactions in testis or spermatozoa by co-IP.
Nevertheless, expression and localization of SPACA6 and other
fusion-related sperm proteins can be examined in Izumo1 KO
spermatozoa to shed light on their potential relationships during
fertilization.
Cultured cells overexpressing IZUMO1 can tightly attach to
the plasma membrane of mouse oocytes (16, 17, 37). Such ad-
hesion is believed to originate from the interaction between
IZUMO1 overexpressed on the plasma membrane of HEK293T
cells and the receptor of IZUMO1, JUNO, on the oocyte mem-
brane. In comparison, according to our present study, transient
expression of other fusion-related sperm proteins does not bestow
HEK293T cells with the ability to adhere to the oocyte surface.
Thus, it is possible that FIMP, SOF1, TMEM95, and SPACA6 do
not possess a counterpart on the oocyte plasma membrane, or the
interactions between the ligands and receptors are too weak to
recapitulate in vitro. HEK293T cells expressing all five proteins
did not show improved binding or an ability to fuse with ZP-free
oocytes. Thus, these five proteins are not sufficient for fusion to
occur. Nevertheless, it is conceivable that membrane fusion be-
tween spermatozoa and oocytes is a highly orchestrated and dy-
namic process that requires strict timing and proper interplay of
different molecules to enable the sperm head to internalize into
the ooplasm. Future investigations are required to optimize the
experimental conditions to recapitulate gamete fusion using cul-
tured cells and ZP-free oocytes.
In conclusion, we discovered three genes, Sof1, Tmem95, and
Spaca6, that encode sperm proteins required for fusion with
oocytes. The amount and localization of IZUMO1 in these KO
spermatozoa were normal. Overexpression of these proteins did
not endow cultured cells with the ability to bind to or fuse with
oocyte plasma membrane. Thus, it is tempting to speculate that
SOF1, TMEM95, and SPACA6 may directly or indirectly regu-
late membrane fusion via an IZUMO1-independent pathway or
act as fusion mediators downstream of the interaction between
IZUMO1 and JUNO. This research emphasizes the multifacto-
rial nature of the membrane fusion between spermatozoon and
oocyte. The discovery of novel fusion-related proteins may have
profound implications in unveiling the mechanism of gamete
fusion at the molecular level.
Materials and Methods
Animals. B6D2F1, C57BL/6J, and ICR mice were purchased from Japan SLC or
CLEA Japan. Mice were acclimated to a 12-h-light/12-h-dark cycle. All animal
experiments were approved by the Animal Care and Use Committee of
the Research Institute for Microbial Diseases, Osaka University, Japan
(#Biken-AP-H30-01).
Sample Collection and Analyses. For the multitissue expression analyses, brain,
thymus, lung, heart, liver, spleen, kidney, testis, epididymis (caput, corpus,
and cauda regions), seminal vesicle, prostate (mixture of dorsal, lateral, and
ventral regions), coagulating gland (also known as anterior prostate), ovary,
and uterus were collected from adult C57BL/6J mice. These samples were
processed in TRIzol (Ambion). For Western blot analysis, TGC proteins were
extracted with lysis buffer containing Triton-X 100 (50 mM NaCl, 10 mM Tris·
HCl, 1% [vol/vol] Triton-X 100 [Sigma Aldrich], pH 7.5) containing 1% (vol/vol)
protease inhibitor mixture (Nacalai Tesque). Proteins of cauda epididymal
spermatozoa were extracted with sample buffer containing β-mercaptoethanol
(Nacalai Tesque) as described previously (38).
RT-PCR for Tissue Expression Analysis. The total RNA was reverse-transcribed
to cDNA using a SuperScript III First-Strand Synthesis System for RT-PCR
(Invitrogen). PCR conditions with primer sets (SI Appendix, Table S1) and
KOD DNA Polymerase (KOD-Fx neo; TOYOBO) were 94 °C for 3 min, de-
naturing at 94 °C for 30 s, annealing at 65 °C for 30 s, and elongation 72 °C
for 30 s for 35 cycles in total, followed by 72 °C for 2 min.
Generation of KOMice. The generation of genetically modified mice was done
as described previously (26, 39). Specifically, Sof1 del/delmice were produced
by introducing pX459 plasmid (https://www.addgene.org/62988/) into mouse
ES cells (EGR-G01) as described previously (28, 39). The mutant ES cells were
injected into morula-stage embryos of the ICR strain. The germ line trans-
mission was confirmed by mating the obtained chimeric males with B6D2F1
females. Tmem95 del/del and Spaca6 del/del mice were generated by in-
troducing gRNA/CAS9 protein solution into fertilized eggs (B6D2 back-
ground) with an electroporator (Nepagene) (26). A search for gRNA and off-
target sequences was performed using CRISPRdirect software (https://crispr.
dbcls.jp/) (40) and Benchling (https://www.benchling.com/academic/). The
screening of the obtained mutant mice was performed by direct sequencing
following PCR. The gRNAs and primers used are listed in SI Appendix, Table
S2. Detailed genotype information of mutant mouse lines is shown in SI
Appendix, Figs. S2, S4, and S7.
Generation of Tg Mice. Sequences of mouse Sof1 cDNA-PA tag, mouse
Tmem95 cDNA-1D4 tag, and mouse Spaca6 cDNA-1D4 tag with a rabbit
polyA signal were inserted under the control of the mouse Clgn promoter (SI
Appendix, Figs. S2G, S6A, and S9A). The linearized DNA was injected into a
pronucleus of fertilized eggs, and injected eggs were transferred to
































pseudopregnant females. After 19 d, offspring were obtained by natural
birth or Caesarean section. Offspring carrying the transgene were screened
by PCR (SI Appendix, Table S3).
In Vivo Fertilization. Pregnant mare serum gonadotropin (5 units; ASKA
Pharmaceutical) or Center for Animal Resources and Development (CARD)
HyperOva (0.1 mL; Kyudo) was injected into the abdominal cavity of B6D2F1
females, followed by naturalmatingwithmutantmalemice 12 h after human
coagulating gland (hCG; 5 units, ASKA Pharmaceutical) injection. After 6 h to
9 h of mating, we observed the collected oocytes.
Mating Test. KO male mice were caged with two or three B6D2F1 females for
more than 1 mo. After the mating period, the male mice were withdrawn
from the cages, and the females were kept for another 20 d to allow them to
deliver any possible final litters. Frozen spermatozoa from Sof1, Tmem95,
and Spaca6 del/wt males (STOCK Llcfc1<em2Osb>, RBRC#10352, CARD#2722;
STOCK Llcfc1<em3Osb>, RBRC#10353, CARD#2723; B6D2-Spaca6<em1Osb>,
RBRC#10325, CARD#2695; and B6D2-Tmem95<em1Osb>, RBRC#11046, CARD#2953)
will be available through RIKEN BRC (http://en.brc.riken.jp/index.shtml) and CARD
R-BASE (http://cardb.cc.kumamoto-u.ac.jp/transgenic/).
Sperm Morphology and Motility and IVF of Cauda Epididymal Spermatozoa.
Cauda epididymal spermatozoa were dispersed in phosphate-buffered sa-
line (PBS) (for sperm morphology) or TYH drops (for sperm motility and IVF)
(41). After an incubation period of 10 and 120 min in TYH, sperm motility
patterns were examined using the CEROS I and II sperm analysis system
(42–44). IVF was performed as described previously (45).
Fusion Assay. The fusion assay was performed as described previously (9).
Specifically, cauda epididymal spermatozoa were incubated in TYH drops for
2 h to 3 h before the fusion assay. Unfertilized oocytes were collected from
hormone-treated females 14 h after hCG injection. To remove the ZP, oo-
cytes were treated with 1 mg/mL collagenase (C1639; Sigma Aldrich) for
10 min. After washing in TYH, oocytes were stained with Hoechst 33342
(1:10,000) for 10 min and washed repeatedly in clean TYH drops. For in-
semination, 1 × 105 spermatozoa per mL were used. After 30 min of in-
cubation, oocytes were fixed with 0.25% glutaraldehyde (Wako) or 0.2%
paraformaldehyde (PFA).
Antibodies. A rat monoclonal antibody against mouse SOF1 (amino acid #22-
#89, ENSMUST00000031900) was generated as described in SI Appendix.
Monoclonal antibodies for SLC2A3 (KS64-10), IZUMO1 (KS64-125), and
ADAM1B (KS107-158) were generated in our laboratory (46, 47). The anti-
1D4 antibody was generated using a hybridoma cell line as a gift from
Robert Molday, Ophthalmology and Visual Sciences, Centre for Macular
Research, University of British Columbia, Vancouver, British Columbia, Can-
ada (48). A polyclonal antibody for BASIGIN was purchased from Santa Cruz
Biotechnology (sc-9757). A monoclonal antibody against β-Actin (ACTB) was
purchased from Abcam (ab6276). A monoclonal and a polyclonal antibody
against FLAG were purchased from Sigma Aldrich (F1804) and MBL (PM020),
respectively. Horseradish peroxidase (HRP)-conjugated goat anti-rat immun-
oglobulins (IgGs) (112-035-167), HRP-conjugated goat anti-mouse IgGs (115-
036-062), and HRP-conjugated bovine anti-goat IgGs antibodies (805-035-180)
were purchased from Jackson ImmunoResearch Laboratories. Fluorophore-
conjugated secondary antibodies goat-anti rat IgG Alexa Fluor 488 (A11006),
goat-anti rat IgG Alexa Fluor 546 (A11081), goat-anti mouse IgG Alexa Fluor
488 (A11017), and goat-anti mouse IgG Alexa Fluor 546 (A11018) were pur-
chased from Thermo Fisher Scientific.
Western Blot Analysis. Before sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS/PAGE), all samples were mixed with sample buffer
containing β-mercaptoethanol (38) and boiled at 95 °C for 5 min. Poly(vinylidene
difluoride) membrane was treated with Tris-buffered saline (TBS)-0.1% Tween 20
(Nacalai Tesque) containing 10% skim milk for 1 h, followed by the primary
antibody (nondilution [SOF1], 1:1,000 [SLC2A3, IZUMO1, ACTB, FLAG, and
BASIGIN], 1:3,000 [1D4]) for 3 h at room temperature or overnight at 4 °C. After
washing with TBS-0.1% Tween 20, the membrane was further probed with the
secondary antibody (1:1,000 [SOF1, SLC2A3, IZUMO1, ACTB, FLAG and 1D4],
1:5,000 [BASIGIN]) for 1 h. The protein bands were visualized by Amersham ECL
Prime Western blot detection reagent (GE Healthcare).
Immunocytochemistry. After 10 min or 2 h of incubation in TYH drops,
spermatozoa were pelleted by centrifugation, washed in PBS, and smeared
and dried on microscope slides. The samples were fixed with 1% PFA, fol-
lowed by permeabilizing with 1% Triton X-100 (Sigma Aldrich). The sper-
matozoa were then blocked with 10% goat serum (Gibco) for 1 h. The
spermatozoa were subjected to immunostaining with anti-IZUMO1 or anti-
1D4 antibody (1:200). Goat-anti rat or mouse IgG Alexa Fluor 488 or 546
(1:300) was used as the secondary antibody. HEK293T cells were seeded on
coverslips coated with poly-L-lysine (Sigma Aldrich) and transfected with
different expression vectors encoding proteins of interest. The cells were
fixed in 4% PFA, permeabilized with 0.1% Triton X-100, and blocked with
10% goat serum for 1 h. The cells were then probed with anti-1D4 or anti-
FLAG antibody (1:200), followed by secondary antibody goat-anti mouse IgG
Alexa Fluor 546 (1:200).
Ca2+ Ionophore A23187 Treatment. A23187 treatment was performed as de-
scribed previously to induce the acrosome reaction in cauda epididymal sper-
matozoa (49). Specifically, spermatozoa from ICR male mice were preincubated
in a TYH drop for 1 h. The spermatozoa were subsequently incubated in a TYH
drop containing 10 μM A23187 (Merck) or 0.5% (vol/vol) dimethyl sulfoxide
(DMSO) (Sigma Aldrich) for 1 h. After washing with PBS, stimulation of the
acrosome reaction in the spermatozoa was confirmed by the translocation of
IZUMO1, and the spermatozoa were subjected to Western blot analysis.
Co-IP. Testis or HEK293T cell lysates, extracted using lysis buffer (50 mM Tris
[pH 7.5], 150 mM NaCl, 1% Triton X-100, 10% Glycerol, 1 mM dithiothreitol,
and 1% protease inhibitor mixture in distilled water), were incubated with
antibody-conjugated Pierce Protein A/G Magnetic Beads (Thermo Fisher
Scientific) for 1 h at 4 °C. After washing three times with wash solution
(50 mM Tris [pH 7.5], 150 mM NaCl, 0.1% Triton X-100, and 10% Glycerol in
distilled water), protein complexes were eluted with SDS sample buffer
supplemented with 5% β-mercaptoethanol and denatured at 70 °C for
10 min. Proteins were then separated by SDS/PAGE and analyzed by Western
blot analysis.
HEK293T−Oocyte Binding Assay. Izumo1, Sof1, Tmem95, Spaca6, and Fimp
ORFs were cloned from mouse testis cDNA, a Kozak sequence was added
upstream of the ATG start codon, and a sequence containing an epitope tag
was added in-frame prior to the stop codon, using RT-PCR. The PCR ampli-
cons were inserted into the pCAG1.1 vector bearing a CAG promoter and a
rabbit beta-globin polyadenylation signal. HEK293T cells were transfected
with expression vectors by calcium phosphate−DNA coprecipitation method
(39). After 2 d of incubation, transfected HEK293T cells were resuspended in
PBS containing 10 mM (ethylenedinitrilo)tetraacetic acid and stained with
Hoechst 33342. ZP-free oocytes were collected as described above. The ZP-
free oocytes were incubated with HEK293T cells overexpressing different
proteins of interest in TYH for 2 h and observed under a Nikon Eclipse Ti
confocal laser scanning microscope. Oocytes were subsequently incubated in
potassium simplex optimization medium for a longer period to find out
whether the cultured cells would fuse with the oocyte plasma membrane.
Statistical Analyses. All values are shown as the mean ± SD of at least three
independent experiments. Statistical analyses were performed using the
Student’s t test, after examining normal distribution and variance.
Data Availability Statement. All data are included in the paper or SI Appendix.
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